(Q40684194)

22 September 2017

Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses (English)

1 reference

22 September 2017

H A Glick

1

1 reference

22 September 2017

A H Briggs

series ordinal

2

1 reference

22 September 2017

D Polsky

series ordinal

3

1 reference

22 September 2017

language of work or name

1 reference

1 October 2001

1 reference

Expert Review of Pharmacoeconomics & Outcomes Research

22 September 2017

1 reference

22 September 2017

1

1 reference

22 September 2017

1

1 reference

22 September 2017

25-36

1 reference

Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial.

22 September 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.1.25

Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.1.25

Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.1.25

Confidence intervals for cost-effectiveness ratios: a comparison of four methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.1.25

The CE plane: a graphic representation of cost-effectiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.1.25

Use of an angular transformation for ratio estimation in cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.1.25

Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.1.25

Incremental net benefit in randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.1.25

Treatment of early-stage breast cancer in the elderly: a health-outcome-based approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.1.25

Analysis, sample size, and power for estimating incremental net health benefit from clinical trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.1.25

Handling uncertainty in cost-effectiveness models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.1.1.25

21 January 2018

Identifiers

DOI

10.1586/14737167.1.1.25

1 reference

22 September 2017

1 reference